Buy, Sell or Hold: BioCryst Pharmaceuticals (BCRX-Q)

Home

Daily Stock Opinions and Ratings

BioCryst Pharmaceuticals (BCRX-Q)

NASDAQ:BCRX

10.16

0.08 (0.74%) 1d

Nervous markets await Nvidia

COMMENT

They had promised to do a lot of things that didn't happen, but he's willing to keep an open mind and hear what they have to say (would book them to talk about it on his show).

Showing 1 to 1 of 1 entries

BioCryst Pharmaceuticals(BCRX-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for BioCryst Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

BioCryst Pharmaceuticals(BCRX-Q) Frequently Asked Questions

What is BioCryst Pharmaceuticals stock symbol?

BioCryst Pharmaceuticals is a American stock, trading under the symbol BCRX-Q on the NASDAQ (BCRX). It is usually referred to as NASDAQ:BCRX or BCRX-Q

Is BioCryst Pharmaceuticals a buy or a sell?

In the last year, there was no coverage of BioCryst Pharmaceuticals published on Stockchase.

Is BioCryst Pharmaceuticals a good investment or a top pick?

BioCryst Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for BioCryst Pharmaceuticals.

Why is BioCryst Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is BioCryst Pharmaceuticals worth watching?

In the last year, there was no coverage of BioCryst Pharmaceuticals published on Stockchase.

What is BioCryst Pharmaceuticals stock price?

On 2025-05-08, BioCryst Pharmaceuticals (BCRX-Q) stock closed at a price of $10.155.

Most Recent Experts

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.